课题基金 / 基金详情

GABAergic neurogenesis in humans and the effect of prematurity

GABAergic neurogenesis in humans and the effect of prematurity
人类 GABA 能神经发生和早产的影响
批准号:
8769736
负责人:
PRAVEEN BALLABH
金额:
$24.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-06-01 至 2016-05-31

项目摘要

项目成果

PRAVEEN BALLABH的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Inattention, hyperactivity, autism, emotional disturbance, social incompetence, epilepsy, and lower intellectual abilities are found in about 50% of preterm-born children. These disorders are attributed to an imbalance between inhibitory GABAergic and excitatory glutamatergic transmission in neuronal circuits. Premature birth and associated complications---hypoxia, hypotension, and sepsis--can affect the generation of GABAergic interneurons and disrupt neuronal circuitry. Therefore, we ask how interneurons develop in the second half of pregnancy, and how prematurity disrupts their generation, density, and distribution. Answering these questions will determine the bases of cognitive and behavioral disorders in preterm-born children. Interneurons releasing GABA constitute the major population of cortical inhibitory neurons and are classified based on the neuropeptides they produce. They are generated into both dorsal subventricular zone (SVZ) and ventral SVZ (ganglionic eminence, GE) in humans and only in GE in rodents. Their formation is regulated by transcription factors including, Nkx2.1, Dlx1/2, Lhx6, and Mash1. Prematurity can impact the development of interneurons. This is because oxygen level regulates neurogenesis and preterm birth deprives the infants of the hypoxic intrauterine environment along with the placental hormones and maternal nutrients. Despite this, the development of interneurons has not been studied in the second half of pregnancy and there is no information on how premature birth affects interneurons. Therefore, we hypothesize that a) interneurons and their precursors undergo distinct developmental changes in their density, proliferation, and distribution with advance in gestational age and that b) prematurity disrupts their generation and distribution. Our approach is to a) use human tissues for studying interneuron development in late pregnancy and b) employ both human samples and a rabbit model to assess the effect of prematurity on GABAergic neurogenesis. Human studies are imperative as the human cortex is unique and more complex than animals. Aim #1: Generation of late-born interneurons (20-40 weeks): Evaluate a) the proliferation and density of subtypes of interneurons-GABA+, parvalbumin+, calretinin+, somatostatin+-and their precursors-Nkx2.1+, Dlx1/2+, Mash1+, and b) gene expression of transcription factors regulating GABAergic neurogenesis, Nkx2.1, Dlx1/2, Lhx6, Mash1, in the dorsal SVZ and GE of human fetuses & preterm infants (20-40 weeks). Aim #2: Effect of prematurity on GABAergic neurogenesis: A) HUMAN: Compare the density and proliferation of a) subtypes of interneurons, and b) their progenitors (Dlx1/2+, Nkx2.1+, and Mash1+) in the GE and dorsal SVZ between two sets of premature infants- long postnatal survival (24 week gestational age + 2 week old=26 weeks) vs. short postnatal survival (26 wk gestation + <3d old=26 weeks)--of equivalent postmenstrual age (gestational age + postnatal age) B) RABBIT model: To compare preterm (E29, 3 d old) and term (E32,<2 h old) pups of an equivalent postmenstrual age for parameters as in human experiments.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Intraventricular Hemorrhage Disrupts the Blood Brain Barrier in Premature Infants
Intraventricular Hemorrhage Disrupts the Blood Brain Barrier in Premature Infants
Intraventricular Hemorrhage Disrupts the Blood Brain Barrier in Premature Infants
Intraventricular Hemorrhage Affects Production of Cortical Interneurons
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: